Active Ingredient: LITHIUM CITRATE
Proprietary Name: LITHIUM CITRATE
Dosage Form; Route of Administration: SYRUP; ORAL
Strength: EQ 300MG CARBONATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018421
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
